The healthcare sector comprises numerous subordinate industries, including large pharmaceutical groups as well as medical device manufacturers, medical care centres, hospitals and nursing homes. Driven by demographic change, increasing global prosperity and new research findings, the healthcare sector is increasingly becoming a mainstay of the German economic system. At the same time, the healthcare and social services sector is affected by a constantly increasing pressure on profitability. Costly development and approval processes increase cost pressure and favour an extremely competitive market. Furthermore, technological developments such as digital health platforms and diagnostics through artificial intelligence are also gaining ground. The biotech sector will also have a significant influence on the healthcare sector in the future. In order to maintain and expand their own competitiveness, companies depend on precise planning, lean value creation and the provision of high-quality products and services. High market entry barriers and a high degree of regulation, both nationally and internationally, make M&A transactions a complex undertaking. To take advantage of the opportunities of the booming healthcare market for your individual purchases and sales, you need a partner who is up to these challenges. As CF-MB, we have already successfully advised our clients in healthcare-related transactions in the past. With our many years of expertise, we can help you, for example, to find suitable target companies, conduct a thorough due diligence or sell your own company to a strategic investor. In addition, we offer you a professional, objective and independent valuation of your company or take care of your company succession. Feel free to contact us and ask for our references.
Our services at a glance:
- Identification of potential purchase candidates to strengthen your own competitiveness
- Support in the implementation of a professional due diligence
- Support in the preparation of business plans and implementation of an independent and professional company valuation
- Full support for a company sale due to a lack of a succession plan or a partial sale of company shares to realize further growth steps